Danish drugmaker Bavarian Nordic said on Thursday that it was “better prepared” to supply its mpox vaccine for the current surge of the virus than it was for the 2022 epidemic.
Danish drugmaker Bavarian Nordic said on Thursday that it was “better prepared” to supply its mpox vaccine for the current surge of the virus than it was for the 2022 epidemic.